Skip to main content
background gradient

Volume 15•Issue 10

Industry Update

Open Access
Access in all areas? A round-up of developments in market access and health technology assessment: part 16
  • Sreeram V Ramagopalan and
  • Annie Jullien Pannelay
e260153
Published Online:27 August 2026
Preview Abstract

Short Report

Open Access
Validation of an all-source composite mortality endpoint in the US population
  • Yanina Natanzon,
  • Lukas Slipski, and
  • Mark S Walker
e250198
Published Online:31 August 2026
Preview Abstract

Research Article

Open Access
Indirect treatment comparisons find enhanced effectiveness of pegcetacoplan versus crovalimab in both complement inhibitor-naïve and -experienced patients with paroxysmal nocturnal hemoglobinuria
  • Raymond Siu Ming Wong,
  • Koo Wilson,
  • Zalmai Hakimi,
  • Mikolaj Parkitny,
  • Piotr Wojciechowski,
  • Catherine Flynn, and
  • Francis Fatoye
e260015
Published Online:24 August 2026
Preview Abstract
Open Access
US population-level model of clinical impact of lorlatinib treatment on ALK+ metastatic non-small cell lung cancer outcomes
  • Adam Kasle,
  • Devin Abrahami,
  • David Veenstra,
  • Robert Morlock,
  • Priya Ramachandran,
  • Lindsay Stansfield, and
  • Raymond Mak
e260096
Published Online:3 September 2026
Preview Abstract
Open Access
A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study
  • Philippe Debonnaire,
  • Peter-Paul Zwetsloot,
  • Roman Pfister,
  • Pau Llàcer,
  • Alberto Cipriani,
  • Paolo Milani,
  • Diana Bonderman,
  • Christoph Ohlmeier,
  • Thomas Evers,
  • Richard Wyss,
  • Elisabetta Patorno,
  • Riddhi Doshi,
  • Julien Beisel,
  • Craig I Coleman,
  • Carlos Aguiar, and
  • Tomas Ripoll-Vera
e260114
Published Online:14 September 2026
Preview Abstract
Open Access
Cost-effectiveness of a connected injection device for daily somatropin therapy in pediatric growth hormone deficiency in Spain: a scenario-based microsimulation analysis using real-world data
  • Antonio de Arriba,
  • Claudia Roeder,
  • Emilia Nivelle,
  • Paula van Dommelen,
  • Jose J Alcón Sáez,
  • Cristina Latre Gorbe,
  • Heidi de los Santos Real,
  • Irene Sánchez-Collado,
  • Falko Boehm, and
  • Cristina Masseria
e260093
Published Online:10 September 2026
Preview Abstract
Open Access
Indirect treatment comparison of odevixibat and maralixibat for the treatment of cholestatic pruritus in patients with Alagille syndrome
  • Emmanuelle Kaltenbach,
  • Alice Guiraud-Diawara,
  • Jérémie Schwarzbard, and
  • Cécile Artaud
e260138
Published Online:18 September 2026
Preview Abstract

Meta-Analysis

Open Access
Comparative efficacy of various wound dressings on scar formation following thyroidectomy: a systematic review and meta-analysis
  • Yixue Jiang
e260101
Published Online:4 September 2026
Preview Abstract
Open Access
Prognostic value of liver histology in steatotic liver disease: a systematic literature review and meta-analysis
  • A Sidney Barritt,
  • Anila Qasim,
  • Yestle Kim,
  • Sally D Miller,
  • John O'Donnell, and
  • Karissa Johnston
e260148
Published Online:3 September 2026
Preview Abstract

Perspective

Open Access
Rigorous, transparent and inconclusive: what Europe’s first joint clinical assessment reveals about a framework trying to serve everyone
  • Ramiro Gilardino,
  • Antonella Cardone, and
  • Carlos M Cossio
e2600141
Published Online:17 September 2026
Preview Abstract
Open Access
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital
  • Richard Z Xie
e260087
Published Online:15 September 2026
Preview Abstract